Immunocore Holdings plc (IMCR) Tops Q3 EPS by 24c

Immunocore Holdings plc (NASDAQ: IMCR) reported Q3 EPS of $0.00, $0.24 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $103.69 million versus the consensus estimate of $101.94 million.

For earnings history and earnings-related data on Immunocore Holdings plc (IMCR) click here.

You May Also Be Interested In

• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Seaport Global Securities Upgrades Analog Devices (ADI) to Buy, 'appears to be entering the sweet part of the cycle'
• Zoetis Inc. (ZTS) PT Lowered to $80 at Stifel as Key Franchise Price Realization Decelerates